The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000277.1(PAH):c.1039C>T (p.Leu347Phe)

CA229296

102488 (ClinVar)

Gene: PAH
Condition: phenylketonuria
Inheritance Mode: Autosomal recessive inheritance
UUID: ff17bdce-39eb-49fe-bc18-7aab80634091
Approved on: 2024-11-17
Published on: 2024-11-18

HGVS expressions

NM_000277.1:c.1039C>T
NM_000277.1(PAH):c.1039C>T (p.Leu347Phe)
NC_000012.12:g.102844362G>A
CM000674.2:g.102844362G>A
NC_000012.11:g.103238140G>A
CM000674.1:g.103238140G>A
NC_000012.10:g.101762270G>A
NG_008690.1:g.78241C>T
NG_008690.2:g.119049C>T
ENST00000553106.6:c.1039C>T
ENST00000307000.7:c.1024C>T
ENST00000549247.6:n.798C>T
ENST00000551114.2:n.701C>T
ENST00000553106.5:c.1039C>T
ENST00000635477.1:c.143C>T
ENST00000635528.1:n.554C>T
NM_000277.2:c.1039C>T
NM_001354304.1:c.1039C>T
NM_000277.3:c.1039C>T
NM_001354304.2:c.1039C>T
More

Likely Pathogenic

Met criteria codes 4
PM2_Supporting PP3_Strong PP4_Moderate PM3_Supporting
Not Met criteria codes 2
BP4 PM5

Evidence Links 2

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Phenylketonuria Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for PAH Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.1039C>T (p.Leu347Phe) variant in PAH has been reported twice in patients with PAH deficiency with BH4 deficiency excluded (PMID: 8659548, 21147011) (PP4_Moderate). One of these individuals was homozygous for the variant (PMID: 21147011) (PM3_Supporting). This variant is absent in population databases (PM2_Supporting). Multiple lines of computational evidence support a deleterious effect, including REVEL score 0.951 (PP3_Strong). In summary, this variant meets criteria to be classified as likely pathogenic for phenylketonuria in an autosomal recessive manner based on the ACMG/AMP criteria applied as specified by the PAH Expert Panel: PM2_Supporting, PP4_Moderate, PM3_Supporting, PP3_Strong.
Met criteria codes
PM2_Supporting
Absent from gnomAD v4.1.0
PP3_Strong
Predicted deleterious in SIFT, Polyphen2, MutationTaster, REVEL=0.951
PP4_Moderate
L347F found in 2 hyperphenylalaninemic patients. BH4 deficiency excluded in 1 patient Assessment included PAH gene and genes of the BH4 synthesis/recycling pathways (PTS and QDPR). PMID: 8659548, PMID: 21147011

PM3_Supporting
PMID: 21147011: L347F found in homozygous state in 1 patient. parental analysis not reported (0.5pts)

Not Met criteria codes
BP4
Predicted deleterious in SIFT, Polyphen2, MutationTaster
PM5
Only variant in codon
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.